{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:10:16Z","timestamp":1749096616687,"version":"3.41.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","award":["09120012010023"],"award-info":[{"award-number":["09120012010023"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["12949","14726"],"award-info":[{"award-number":["12949","14726"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["724281"],"award-info":[{"award-number":["724281"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Research Council","award":["101112687"],"award-info":[{"award-number":["101112687"]}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["Gravitation programme IMAGINE! (project number 24.005.009","the Institute of Chemical Immunology (project ICI 000-23)"],"award-info":[{"award-number":["Gravitation programme IMAGINE! (project number 24.005.009","the Institute of Chemical Immunology (project ICI 000-23)"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>CD151 is a broadly expressed four-transmembrane protein (tetraspanin) that interacts with laminin\u2010binding integrins like integrin alpha 3 (ITGA3). CD151 drives tumor development and expression correlates with poor prognosis in solid cancers, but CD151 has not been studied in B cell malignancies. We investigated CD151 expression on normal human B cells and B cell lymphomas using highly sensitive flow cytometry and immunohistochemistry. Expression of CD151 increased during B cell differentiation from na\u00efve to memory B cells to plasma cells. B lymphoma cell lines and human lymphoma biopsy samples expressed higher levels of CD151 compared to normal B cells, but CD151\u2010deficient lymphomas were identified as well. To investigate the function of CD151 in B cells, CD151\u2010deficient and stably transduced CD151 expressing B lymphoma cell lines were generated. Immunoprecipitation-mass spectrometry analysis of CD151 protein complexes identified integrin beta 2 (ITGB2) as new interaction partner in lymphoma cells. Deficiency of CD151 decreased cell surface expression of alpha integrin subunits L (ITGAL) and M (ITGAM), and impaired ICAM-1-mediated cell spreading. Interestingly, B cells and lymphomas did not express ITGA3\u2010bound CD151 compared to T cells that expressed two different populations of integrin\u2010bound and integrin\u2010free CD151. Despite CD151 expression not being related to clinical outcome of patients with diffuse large B cell lymphoma (DLBCL), CD151 expression was predominantly detected in the activated (ABC) subset of DLBCL. Taken together, we identified a new molecular association of CD151 with ITGB2, and targeting integrin-free CD151 in DLBCL may represent a new target for immunotherapy.<\/jats:p>","DOI":"10.1007\/s00018-025-05747-0","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:46:15Z","timestamp":1749026775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD151 interacts with integrin beta 2 in B cell lymphomas"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2139-9471","authenticated-orcid":false,"given":"Philipp M.","family":"Hagemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9295-1923","authenticated-orcid":false,"given":"Angelique N.","family":"Kenyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-3794","authenticated-orcid":false,"given":"Alfredo","family":"Cabrera-Orefice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6727-3273","authenticated-orcid":false,"given":"Abbey B.","family":"Arp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0319-7505","authenticated-orcid":false,"given":"Eva A. M.","family":"Hesius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-6254","authenticated-orcid":false,"given":"Michiel","family":"van den Brand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8972-6665","authenticated-orcid":false,"given":"Sjoerd J.","family":"van Deventer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-4060","authenticated-orcid":false,"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8029-9230","authenticated-orcid":false,"given":"Blanca","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7615-3949","authenticated-orcid":false,"given":"Zijun Y.","family":"Xu-Monette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-6811","authenticated-orcid":false,"given":"Ulrich","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1789-670X","authenticated-orcid":false,"given":"Cornelia G.","family":"Spruijt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-6894","authenticated-orcid":false,"given":"Michiel","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"ter Beest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5755-8932","authenticated-orcid":false,"given":"Ken H.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-2368","authenticated-orcid":false,"given":"Annemiek B.","family":"van Spriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"5747_CR1","doi-asserted-by":"publisher","unstructured":"Ashman LK, Aylett GW, Mehrabani PA et al (1991) The murine monoclonal antibody, 14A2.H1, identifies a novel platelet surface antigen. Br J Haematol. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb04531.x","DOI":"10.1111\/j.1365-2141.1991.tb04531.x"},{"key":"5747_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3640","author":"ME Hemler","year":"2014","unstructured":"Hemler ME (2014) Tetraspanin proteins promote multiple cancer stages. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc3640","journal-title":"Nat Rev Cancer"},{"key":"5747_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2003.09.011","author":"JM Tarrant","year":"2003","unstructured":"Tarrant JM, Robb L, van Spriel AB, Wright MD (2003) Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol. https:\/\/doi.org\/10.1016\/j.it.2003.09.011","journal-title":"Trends Immunol"},{"key":"5747_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nri1548","author":"S Levy","year":"2005","unstructured":"Levy S, Shoham T (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/nri1548","journal-title":"Nat Rev Immunol"},{"key":"5747_CR5","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.154906","author":"S Charrin","year":"2014","unstructured":"Charrin S, Jouannet S, Boucheix C, Rubinstein E (2014) Tetraspanins at a glance. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.154906","journal-title":"J Cell Sci"},{"key":"5747_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1736","author":"ME Hemler","year":"2005","unstructured":"Hemler ME (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/nrm1736","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5747_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00935-0","author":"LQ Cano","year":"2024","unstructured":"Cano LQ, Dunlock V-ME, Schwerdtfeger F, van Spriel AB (2024) Membrane organization by tetraspanins and galectins shapes lymphocyte function. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-023-00935-0","journal-title":"Nat Rev Immunol"},{"key":"5747_CR8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-13-0275","author":"TD Palmer","year":"2014","unstructured":"Palmer TD, Mart\u00ednez CH, Vasquez C et al (2014) Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Can Res. https:\/\/doi.org\/10.1158\/0008-5472.can-13-0275","journal-title":"Can Res"},{"key":"5747_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccr.2008.01.031","volume":"13","author":"A Zijlstra","year":"2008","unstructured":"Zijlstra A, Lewis J, DeGryse B et al (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13:221\u2013234. https:\/\/doi.org\/10.1016\/j.ccr.2008.01.031","journal-title":"Cancer Cell"},{"key":"5747_CR10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1512","author":"VK Crew","year":"2004","unstructured":"Crew VK, Burton N, Kagan A et al (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood. https:\/\/doi.org\/10.1182\/blood-2004-04-1512","journal-title":"Blood"},{"key":"5747_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700142","author":"AJ Cowin","year":"2006","unstructured":"Cowin AJ, Adams DH, Geary SM et al (2006) Wound healing is defective in mice lacking tetraspanin CD151. J Investig Dermatol. https:\/\/doi.org\/10.1038\/sj.jid.5700142","journal-title":"J Investig Dermatol"},{"key":"5747_CR12","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200603073","author":"N Sachs","year":"2006","unstructured":"Sachs N, Kreft M, van den Bergh Weerman MA et al (2006) Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol. https:\/\/doi.org\/10.1083\/jcb.200603073","journal-title":"J Cell Biol"},{"key":"5747_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci58878","author":"N Sachs","year":"2012","unstructured":"Sachs N, Claessen N, Aten J et al (2012) Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Investig. https:\/\/doi.org\/10.1172\/jci58878","journal-title":"J Clin Investig"},{"key":"5747_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-022-05447-y","author":"RW Naylor","year":"2022","unstructured":"Naylor RW, Watson E, Williamson S et al (2022) Basement membrane defects in CD151-associated glomerular disease. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-022-05447-y","journal-title":"Pediatr Nephrol"},{"key":"5747_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01998-4","author":"J Zhu","year":"2021","unstructured":"Zhu J, Cai T, Zhou J et al (2021) CD151 drives cancer progression depending on integrin \u03b13\u03b21 through EGFR signaling in non-small cell lung cancer. J Exp Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-021-01998-4","journal-title":"J Exp Clin Cancer Res"},{"key":"5747_CR16","doi-asserted-by":"publisher","DOI":"10.1593\/neo.12922","author":"X Deng","year":"2012","unstructured":"Deng X, Li Q, Hoff JT et al (2012) Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia. https:\/\/doi.org\/10.1593\/neo.12922","journal-title":"Neoplasia"},{"key":"5747_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.136","author":"R Sadej","year":"2014","unstructured":"Sadej R, Grudowska A, Turczyk L et al (2014) CD151 in cancer progression and metastasis: a complex scenario. Lab Invest. https:\/\/doi.org\/10.1038\/labinvest.2013.136","journal-title":"Lab Invest"},{"key":"5747_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601015","author":"H Hashida","year":"2003","unstructured":"Hashida H, Takabayashi A, Tokuhara T et al (2003) Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer. https:\/\/doi.org\/10.1038\/sj.bjc.6601015","journal-title":"Br J Cancer"},{"key":"5747_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04928-0","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wang A, Cai T et al (2022) Integrin \u03b13\/\u03b16 and \u03b1V are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-022-04928-0","journal-title":"Cell Death Dis"},{"key":"5747_CR20","doi-asserted-by":"publisher","unstructured":"Peng D, Li P, Liu T et al (2020) Key role of CD151-integrin complex in lung cancer metastasis and mechanisms involved. null. https:\/\/doi.org\/10.1007\/s11596-020-2297-7","DOI":"10.1007\/s11596-020-2297-7"},{"key":"5747_CR21","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2774","author":"P Li","year":"2015","unstructured":"Li P, Zeng H, Qin J et al (2015) Effects of tetraspanin CD151 inhibition on A549 human lung adenocarcinoma cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2014.2774","journal-title":"Mol Med Rep"},{"key":"5747_CR22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-04-1935","author":"S Gesierich","year":"2005","unstructured":"Gesierich S, Paret C, Hildebrand D et al (2005) Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-1935","journal-title":"Clin Cancer Res"},{"key":"5747_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1416-x","author":"G-H Zhu","year":"2011","unstructured":"Zhu G-H, Huang C, Qiu Z-J et al (2011) Expression and prognostic significance of CD151, c-met, and integrin alpha3\/alpha6 in pancreatic ductal adenocarcinoma. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-010-1416-x","journal-title":"Dig Dis Sci"},{"key":"5747_CR24","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5504-9","author":"OM Fisher","year":"2016","unstructured":"Fisher OM, Levert-Mignon A, Lehane CW et al (2016) CD151 gene and protein expression provides independent prognostic information for patients with adenocarcinoma of the esophagus and gastroesophageal junction treated by esophagectomy. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-016-5504-9","journal-title":"Ann Surg Oncol"},{"key":"5747_CR25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1387-3","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Miyazaki T, Tanaka N et al (2011) Prognostic significance of CD151 expression in esophageal squamous cell carcinoma with aggressive cell proliferation and invasiveness. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-010-1387-3","journal-title":"Ann Surg Oncol"},{"key":"5747_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.80","author":"MA Voss","year":"2011","unstructured":"Voss MA, Gordon NS, Maloney SL et al (2011) Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer. https:\/\/doi.org\/10.1038\/bjc.2011.80","journal-title":"Br J Cancer"},{"key":"5747_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.231","author":"V Novitskaya","year":"2014","unstructured":"Novitskaya V, Romanska H, Kordek R et al (2014) Integrin \u03b13\u03b21\u2013CD151 complex regulates dimerization of ErbB2 via RhoA. Oncogene. https:\/\/doi.org\/10.1038\/onc.2013.231","journal-title":"Oncogene"},{"key":"5747_CR28","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.9.10.2751","author":"RL Yauch","year":"1998","unstructured":"Yauch RL, Berditchevski F, Harler MB et al (1998) Highly stoichiometric, stable, and specific association of integrin \u03b13\u03b21 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell. https:\/\/doi.org\/10.1091\/mbc.9.10.2751","journal-title":"Mol Biol Cell"},{"key":"5747_CR29","doi-asserted-by":"publisher","DOI":"10.1042\/bj3380061","author":"S Fitter","year":"1999","unstructured":"Fitter S, Sincock PM, Jolliffe CN, Ashman LK (1999) Transmembrane 4 superfamily protein CD151 (PETA-3) associates with beta 1 and alpha IIb beta 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J. https:\/\/doi.org\/10.1042\/bj3380061","journal-title":"Biochem J"},{"key":"5747_CR30","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.113.11.1871","author":"CS Stipp","year":"2000","unstructured":"Stipp CS, Hemler ME (2000) Transmembrane-4-superfamily proteins CD151 and CD81 associate with alpha 3 beta 1 integrin, and selectively contribute to alpha 3 beta 1-dependent neurite outgrowth. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.113.11.1871","journal-title":"J Cell Sci"},{"key":"5747_CR31","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.115.6.1161","author":"LMT Sterk","year":"2002","unstructured":"Sterk LMT, Geuijen CAW, Berg JGVD et al (2002) Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.115.6.1161","journal-title":"J Cell Sci"},{"key":"5747_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/mp.a004123.01","author":"T Palmer","year":"2011","unstructured":"Palmer T, Zijlstra A (2011) CD151: basis sequence: mouse. AfCS-Nature Mol Pages. https:\/\/doi.org\/10.1038\/mp.a004123.01","journal-title":"AfCS-Nature Mol Pages"},{"key":"5747_CR33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-2949","author":"XH Yang","year":"2008","unstructured":"Yang XH, Richardson AL, Torres-Arzayus MI et al (2008) CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Can Res. https:\/\/doi.org\/10.1158\/0008-5472.can-07-2949","journal-title":"Can Res"},{"key":"5747_CR34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.13.9230","author":"RL Yauch","year":"2000","unstructured":"Yauch RL, Kazarov AR, Desai B et al (2000) Direct extracellular contact between integrin \u03b13\u03b21 and TM4SF protein CD151. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.275.13.9230","journal-title":"J Biol Chem"},{"key":"5747_CR35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104041200","author":"F Berditchevski","year":"2001","unstructured":"Berditchevski F, Gilbert E, Griffiths MR et al (2001) Analysis of the CD151\u00b7\u03b13\u03b21 integrin and CD151\u00b7tetraspanin interactions by Mutagenesis. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.M104041200","journal-title":"J Biol Chem"},{"key":"5747_CR36","unstructured":"Testa JE, Brooks PC, Lin JM, Quigley JP (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3\/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res. https:\/\/pubmed.ncbi.nlm.nih.gov\/10447000\/"},{"key":"5747_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1158\/0008-5472.CAN-13-0275","volume":"74","author":"TD Palmer","year":"2014","unstructured":"Palmer TD, Mart\u00ednez CH, Vasquez C et al (2014) Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Can Res 74:173\u2013187. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0275","journal-title":"Can Res"},{"key":"5747_CR38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.6.3087","author":"H Hasegawa","year":"1998","unstructured":"Hasegawa H, Nomura T, Kishimoto K et al (1998) SFA-1\/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with \u03b15\u03b21 integrin and regulates adhesion of human t cell leukemia virus type 1-infected t cells to fibronectin. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.161.6.3087","journal-title":"J Immunol"},{"key":"5747_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/mib.0000000000000621","author":"E Zelman-Toister","year":"2016","unstructured":"Zelman-Toister E, Bakos E, Cohen S et al (2016) CD151 regulates t-cell migration in health and inflammatory bowel disease. Inflamm Bowel Dis. https:\/\/doi.org\/10.1097\/mib.0000000000000621","journal-title":"Inflamm Bowel Dis"},{"key":"5747_CR40","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4049\/jimmunol.1700648","volume":"199","author":"L Seu","year":"2017","unstructured":"Seu L, Tidwell C, Timares L et al (2017) CD151 expression is associated with a hyperproliferative T Cell phenotype. J Immunol 199:3336\u20133347. https:\/\/doi.org\/10.4049\/jimmunol.1700648","journal-title":"J Immunol"},{"key":"5747_CR41","doi-asserted-by":"publisher","first-page":"15748","DOI":"10.1038\/s41598-020-72719-8","volume":"10","author":"MD Perez","year":"2020","unstructured":"Perez MD, Seu L, Lowman KE et al (2020) The tetraspanin CD151 marks a unique population of activated human T cells. Sci Rep 10:15748. https:\/\/doi.org\/10.1038\/s41598-020-72719-8","journal-title":"Sci Rep"},{"key":"5747_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.24.13.5978-5988.2004","author":"MD Wright","year":"2004","unstructured":"Wright MD, Geary SM, Fitter S et al (2004) Characterization of mice lacking the tetraspanin superfamily member CD151. Mol Cell Biol. https:\/\/doi.org\/10.1128\/mcb.24.13.5978-5988.2004","journal-title":"Mol Cell Biol"},{"key":"5747_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1084174","author":"M Kim","year":"2003","unstructured":"Kim M, Carman CV, Springer TA (2003) Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science. https:\/\/doi.org\/10.1126\/science.1084174","journal-title":"Science"},{"key":"5747_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.83","author":"C Visco","year":"2012","unstructured":"Visco C, Li Y, Xu-Monette ZY et al (2012) Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large b-cell lymphoma: a report from the international DLBCL rituximab-CHOP consortium program study. Leukemia. https:\/\/doi.org\/10.1038\/leu.2012.83","journal-title":"Leukemia"},{"key":"5747_CR45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-715094","author":"ZY Xu-Monette","year":"2016","unstructured":"Xu-Monette ZY, Ling L, Byrd JC et al (2016) Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood-2016-05-715094","journal-title":"Blood"},{"key":"5747_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1186-3","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jane-Valbuena J et al (2019) Next-generation characterization of the cancer cell line encyclopedia. Nature. https:\/\/doi.org\/10.1038\/s41586-019-1186-3","journal-title":"Nature"},{"key":"5747_CR47","doi-asserted-by":"publisher","unstructured":"DepMap B (2023) DepMap 23Q4 public. https:\/\/doi.org\/10.25452\/figshare.plus.24667905.v2","DOI":"10.25452\/figshare.plus.24667905.v2"},{"key":"5747_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0637-7","author":"H Loeffler-Wirth","year":"2019","unstructured":"Loeffler-Wirth H, Kreuz M, Hopp L et al (2019) A modular transcriptome map of mature b cell lymphomas. Genome Med. https:\/\/doi.org\/10.1186\/s13073-019-0637-7","journal-title":"Genome Med"},{"key":"5747_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2004.00271.x","author":"T Tohami","year":"2004","unstructured":"Tohami T, Drucker L, Radnay J et al (2004) Expression of tetraspanins in peripheral blood leukocytes: A comparison between normal and infectious conditions. Tissue Antigens. https:\/\/doi.org\/10.1111\/j.1399-0039.2004.00271.x","journal-title":"Tissue Antigens"},{"key":"5747_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2748","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA (2010) Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc2748","journal-title":"Nat Rev Cancer"},{"key":"5747_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.04.006","author":"CM de Winde","year":"2017","unstructured":"de Winde CM, Elfrink S, van Spriel AB (2017) Novel insights into membrane targeting of b cell lymphoma. Trends Cancer. https:\/\/doi.org\/10.1016\/j.trecan.2017.04.006","journal-title":"Trends Cancer"},{"key":"5747_CR52","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.114.23.4143","author":"F Berditchevski","year":"2001","unstructured":"Berditchevski F (2001) Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.114.23.4143","journal-title":"J Cell Sci"},{"key":"5747_CR53","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood-2004-04-1512","volume":"104","author":"V Karamatic Crew","year":"2004","unstructured":"Karamatic Crew V, Burton N, Kagan A et al (2004) CD151, the first member of the tetraspanin (TM4) superfamily detected on erythrocytes, is essential for the correct assembly of human basement membranes in kidney and skin. Blood 104:2217\u20132223. https:\/\/doi.org\/10.1182\/blood-2004-04-1512","journal-title":"Blood"},{"key":"5747_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(04)00105-0","author":"YR Carrasco","year":"2004","unstructured":"Carrasco YR, Fleire SJ, Cameron TO et al (2004) LFA-1\/ICAM-1 interaction lowers the threshold of b cell activation by facilitating b cell adhesion and synapse formation. Immunity. https:\/\/doi.org\/10.1016\/s1074-7613(04)00105-0","journal-title":"Immunity"},{"key":"5747_CR55","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.017905","author":"E Arana","year":"2008","unstructured":"Arana E, Harwood NE et al (2008) Regulation of integrin activation through the b-cell receptor. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.017905","journal-title":"J Cell Sci"},{"key":"5747_CR56","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fimmu.2019.00534","volume":"10","author":"A Camponeschi","year":"2019","unstructured":"Camponeschi A, Gerasimcik N, Wang Y et al (2019) Dissecting integrin expression and function on memory B cells in mice and humans in autoimmunity. Front Immunol 10:534. https:\/\/doi.org\/10.3389\/fimmu.2019.00534","journal-title":"Front Immunol"},{"key":"5747_CR57","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4430","author":"LM Lau","year":"2004","unstructured":"Lau LM, Wee JL, Wright MD et al (2004) The tetraspanin superfamily member CD151 regulates outside-in integrin \u03b1IIb\u03b23 signaling and platelet function. Blood. https:\/\/doi.org\/10.1182\/blood-2003-12-4430","journal-title":"Blood"},{"key":"5747_CR58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m303601200","author":"SW Feigelson","year":"2003","unstructured":"Feigelson SW, Grabovsky V et al (2003) The CD81 tetraspanin facilitates instantaneous leukocyte VLA-4 adhesion strengthening to vascular cell adhesion molecule 1 (VCAM-1) under shear flow. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.m303601200","journal-title":"J Biol Chem"},{"key":"5747_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344235","author":"V Rocha-Perugini","year":"2014","unstructured":"Rocha-Perugini V, Gonz\u00e1lez-Granado JM, Tejera E et al (2014) Tetraspanins CD9 and CD151 at the immune synapse support t-cell integrin signaling. Eur J Immunol. https:\/\/doi.org\/10.1002\/eji.201344235","journal-title":"Eur J Immunol"},{"key":"5747_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1146791","author":"A Ghosh","year":"2023","unstructured":"Ghosh A, Khanam A, Ray K et al (2023) CD38: an ecto-enzyme with functional diversity in t cells. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1146791","journal-title":"Front Immunol"},{"key":"5747_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2543","author":"M Z\u00f6ller","year":"2009","unstructured":"Z\u00f6ller M (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc2543","journal-title":"Nat Rev Cancer"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05747-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05747-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:46:18Z","timestamp":1749026778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05747-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5747"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05747-0","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experiments were performed in compliance with Dutch and EU legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"221"}}